{"id":"W4389180400","doi":"10.1158/2767-9764.crc-23-0234","title":"SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Scheme for Promotion of Academic and Research Collaboration; Canadian Institutes of Health Research; Hospital for Sick Children; Government of Canada; Novartis","keywords":"Crizotinib; Neuroblastoma; ALK inhibitor; Cancer research; Anaplastic lymphoma kinase; Ceritinib; In vivo; Biology; Cell culture; Medicine; Lung cancer; Internal medicine; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001540611,0.0003648025,0.0004993617,0.0002219613,0.0001184232,0.0003911037,0.000243522,0.0001830418,0.001044697],"category_scores_gemma":[0.0001409245,0.0001143652,0.0002825336,0.0001345161,0.0001510684,0.0002263908,0.0002095152,0.0006165854,0.0002491168],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003956781,"about_ca_system_score_gemma":0.0003950056,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001058897,"about_ca_topic_score_gemma":0.003247638,"domain_scores_codex":[0.999899,0.00001411751,0.00001082384,0.00001893388,0.00002892725,0.00002805247],"domain_scores_gemma":[0.9999495,0.000006337358,0.00001097228,0.000004329417,0.000005818011,0.00002304408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006744588,0.0003850963,0.0007366783,0.000120601,0.00003726596,0.0001222521,0.00003684571,0.0005556694,0.9862844,0.0001056799,0.0004078869,0.01053331],"study_design_scores_gemma":[0.0003808147,0.006879942,0.01524242,0.00003369701,0.0001433497,0.0008249944,0.00008940155,0.002573526,0.9656609,0.00005367028,0.008095635,0.00002175618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959481,0.001576692,0.0004188765,0.00007063392,0.00003988541,0.00005032837,0.0002390707,0.00006460627,0.001591711],"genre_scores_gemma":[0.995665,0.001216559,0.000591454,0.00003725544,0.0000109659,0.00003881857,0.0008274,0.00001215739,0.001600391],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001058897,"threshold_uncertainty_score":0.003494859,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0929202335907669,"score_gpt":0.4231044218699909,"score_spread":0.330184188279224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}